In a filing, Altimmune Inc. revealed its Director Pisano Wayne unloaded Company’s shares for reported $0.3 million on Dec 22. In the deal valued at $15.01 per share,20,000 shares were sold. As a result of this transaction, Pisano Wayne now holds 8,498 shares worth roughly $ 91608.43999999999.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Then, Garg Vipin K sold 20,000 shares, generating $400,322 in total proceeds. Upon selling the shares at $20.02, the President and CEO now owns 236,797 shares.
Before that, Garg Vipin K sold 15,000 shares. Altimmune Inc. shares valued at $225,890 were divested by the President and CEO at a price of $15.06 per share. As a result of the transaction, Garg Vipin K now holds 259,804 shares, worth roughly $2.8 million.
Goldman initiated its Altimmune Inc. [ALT] rating to a Buy in a research note published on Monday, December 01, 2022; the price target was $20. PT values the company’s stock at a premium of 46.1 to its Monday closing price. H.C. Wainwright began covering ALT with “Buy” recommendation on June 02, 2021. Guggenheim started covering the stock on February 11, 2021. It rated ALT as “a Buy”.
Price Performance Review of ALT
On Monday, Altimmune Inc. [NASDAQ:ALT] saw its stock jump 3.95% to $10.78. On the same session, the stock had its day’s lowest price of $10.10, but rose to a high of $10.79. Over the last five days, the stock has lost -7.47%. Altimmune Inc. shares have fallen nearly -34.47% since the year began. Nevertheless, the stocks have risen 44.12% over the past one year. While a 52-week high of $23.49 was reached on 01/13/23, a 52-week low of $3.83 was recorded on 03/13/23. SMA at 50 days reached $13.49, while 200 days put it at $12.46. A total of 1.39 million shares were traded, compared to the trading of 1.41 million shares in the previous session.
Levels Of Support And Resistance For ALT Stock
The 24-hour chart illustrates a support level at 10.32, which if violated will result in even more drops to 9.87. On the upside, there is a resistance level at 11.01. A further resistance level may holdings at 11.25. The Relative Strength Index (RSI) on the 14-day chart is 38.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.85%. Stochastics %K at 24.38% indicates the stock is a holding.
How much short interest is there in Altimmune Inc.?
A steep rise in short interest was recorded in Altimmune Inc. stocks on Jan 12, 2023, growing by 0.98 million shares to a total of 7.32 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 6.34 million shares. There was a rise of 13.39%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 15.01% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.86.
Altimmune Inc. [ALT] – Who Are The Largest Shareholders?
In filings from SSgA Funds Management, Inc., it is revealed that the company now owns 5,914,588 shares, or roughly 12.03% of the outstanding ALT shares. In other words, the investor’s shares have risen by 2,515,732 from its previous 13-F filing of 3398856.0. Additionally, Avidity Partners Management LP increased 48.66% of its stake after which the total value it holdings stand at $50,234,100, while Janus Henderson Investors US LLC reduced -7.28% of its stake to hold $48.11 million in the firm. Over the last quarter, TIAA-CREF Investment Management L purchased 52,063 shares of Altimmune Inc., while Tang Capital Management LLC bought 100,000 shares. At present, Cormorant Asset Management LP is holding 2,600,000 shares valued at $32.73 million. The Vanguard Group, Inc. owned 2,481,192 shares of the company at the time of its most recent 13F filing, worth $31.24 million.
However, 8 analysts have rated ALT stock as a Buy in their predictions for 2023. The most recent change occurred on December 14, 2020 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.